These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 11137257

  • 21. A novel method for evaluating natural and vaccine induced serological responses to Bordetella pertussis antigens.
    Berbers GA, van de Wetering MS, van Gageldonk PG, Schellekens JF, Versteegh FG, Teunis PF.
    Vaccine; 2013 Aug 12; 31(36):3732-8. PubMed ID: 23742995
    [Abstract] [Full Text] [Related]

  • 22. Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents.
    Hodder SL, Cherry JD, Mortimer EA, Ford AB, Gornbein J, Papp K.
    Clin Infect Dis; 2000 Jul 12; 31(1):7-14. PubMed ID: 10913389
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A randomised controlled trial with a diphtheria-tetanus-acellular pertussis (dTpa) vaccine in adults.
    Van der Wielen M, Van Damme P, Joossens E, François G, Meurice F, Ramalho A.
    Vaccine; 2000 Apr 14; 18(20):2075-82. PubMed ID: 10715521
    [Abstract] [Full Text] [Related]

  • 26. Proliferative responses to purified and fractionated Bordetella pertussis antigens in mice immunized with whole-cell pertussis vaccine.
    Petersen JW, Andersen P, Ibsen PH, Capiau C, Wachmann CH, Hasløv K, Heron I.
    Vaccine; 1993 Apr 14; 11(4):463-72. PubMed ID: 8470432
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
    Trollfors B, Taranger J, Lagergård T, Sundh V, Bryla DA, Schneerson R, Robbins JB.
    Clin Infect Dis; 1999 Mar 14; 28(3):552-9. PubMed ID: 10194077
    [Abstract] [Full Text] [Related]

  • 30. [A polyvalent complex of Bordetella pertussis antigens as the basis for an acellular pertussis vaccine].
    Zakharova NS, Shmeleva EI, Remova TN, Bazhanova IG, Ozeretskovskaia MN, Mertsalova NU, Britsina MV, Ermolova EV, Zaĭtsev EM.
    Zh Mikrobiol Epidemiol Immunobiol; 1997 Mar 14; (3):70-2. PubMed ID: 9304336
    [Abstract] [Full Text] [Related]

  • 31. Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice.
    Jabbal-Gill I, Fisher AN, Rappuoli R, Davis SS, Illum L.
    Vaccine; 1998 Dec 14; 16(20):2039-46. PubMed ID: 9796062
    [Abstract] [Full Text] [Related]

  • 32. Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitro.
    Queenan AM, Dowling DJ, Cheng WK, Faé K, Fernandez J, Flynn PJ, Joshi S, Brightman SE, Ramirez J, Serroyen J, Wiertsema S, Fortanier A, van den Dobbelsteen G, Levy O, Poolman J.
    Vaccine; 2019 Jan 03; 37(1):80-89. PubMed ID: 30478007
    [Abstract] [Full Text] [Related]

  • 33. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.
    Macdonald-Fyall J, Xing D, Corbel M, Baillie S, Parton R, Coote J.
    Vaccine; 2004 Oct 22; 22(31-32):4270-81. PubMed ID: 15474718
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A novel bivalent acellular pertussis vaccine based on the 69 kDa protein and FHA.
    Novotny P, Chubb AP, Cownley K, Charles IG.
    Dev Biol Stand; 1991 Oct 22; 73():243-9. PubMed ID: 1778316
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Phase I clinical trial of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin combined with FHA and 69 kDa.
    Podda A, Nencioni L, Marsili I, Peppoloni S, Volpini G, Donati D, Di Tommaso A, De Magistris MT, Rappuoli R.
    Vaccine; 1991 Oct 22; 9(10):741-5. PubMed ID: 1759492
    [Abstract] [Full Text] [Related]

  • 39. Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.
    Watanabe M, Nagai M.
    Infect Immun; 2001 Nov 22; 69(11):6981-6. PubMed ID: 11598073
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.